Majumdar, S <br/><br/>
Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Sep 2001 
 - 2911-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.167.5.2911  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>5'-Nucleotidase--antagonists & inhibitors<br/>Adenosine--metabolism<br/>Adenosine Triphosphate--analogs & derivatives<br/>Base Sequence<br/>DNA-Binding Proteins--metabolism<br/>Enzyme Activation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Folic Acid Antagonists--pharmacology<br/>Gene Expression--drug effects<br/>Genes, Reporter--drug effects<br/>HeLa Cells<br/>Humans<br/>I-kappa B Kinase<br/>I-kappa B Proteins<br/>Jurkat Cells<br/>Leucovorin--pharmacology<br/>Methotrexate--pharmacology<br/>NF-KappaB Inhibitor alpha<br/>NF-kappa B--metabolism<br/>Oligodeoxyribonucleotides--genetics<br/>Phosphorylation<br/>Protein Serine-Threonine Kinases--metabolism<br/>Purinergic P1 Receptor Antagonists<br/>Receptor, Adenosine A2B<br/>Theobromine--analogs & derivatives<br/>Thymidine--pharmacology<br/>Transcription Factor AP-1--metabolism<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>U937 Cells